Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients.

Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø.

Mult Scler. 2018 May 1:1352458518779925. doi: 10.1177/1352458518779925. [Epub ahead of print]

PMID:
29862891
2.

Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level.

Eide IA, Dörje C, Svensson M, Jenssen T, Hammarstrøm C, Scott H, Bjerve KS, Christensen JH, Schmidt EB, Hartmann A, Åsberg A, Reisæter AV, Reinholt FP.

J Ren Nutr. 2018 Mar;28(2):118-124. doi: 10.1053/j.jrn.2017.09.001. Epub 2017 Nov 14.

PMID:
29146138
3.

Gestational diabetes and offspring birth size at elevated environmental pollutant exposures.

Valvi D, Oulhote Y, Weihe P, Dalgård C, Bjerve KS, Steuerwald U, Grandjean P.

Environ Int. 2017 Oct;107:205-215. doi: 10.1016/j.envint.2017.07.016. Epub 2017 Jul 25.

PMID:
28753482
4.

Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients.

Eide IA, Åsberg A, Svensson M, Ueland T, Mollnes TE, Hartmann A, Bjerve KS, Michelsen A, Aukrust P, Christensen JH, Schmidt EB, Jenssen T.

J Ren Nutr. 2017 May;27(3):161-168. doi: 10.1053/j.jrn.2016.09.008. Epub 2016 Nov 9.

PMID:
27838193
5.

No association of tobacco use and disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T, Benth JŠ, Løken-Amsrud KI, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Torkildsen Ø.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 14;3(4):e260. doi: 10.1212/NXI.0000000000000260. eCollection 2016 Aug.

6.

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.

Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø.

Eur J Neurol. 2016 Jun;23(6):1064-70. doi: 10.1111/ene.12986. Epub 2016 Mar 21.

PMID:
26998820
7.

Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients.

Eide IA, Dahle DO, Svensson M, Hartmann A, Åsberg A, Bjerve KS, Christensen JH, Schmidt EB, Lauritsen ME, Lund K, Jenssen T.

Eur J Clin Nutr. 2016 Jul;70(7):824-30. doi: 10.1038/ejcn.2016.14. Epub 2016 Mar 2.

PMID:
26931669
8.

Body mass index influence interferon-beta treatment response in multiple sclerosis.

Kvistad SS, Myhr KM, Holmøy T, Šaltytė Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø.

J Neuroimmunol. 2015 Nov 15;288:92-7. doi: 10.1016/j.jneuroim.2015.09.008. Epub 2015 Sep 26.

PMID:
26531700
9.

Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival.

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M.

Nephrol Dial Transplant. 2016 Jan;31(1):160-7. doi: 10.1093/ndt/gfv339. Epub 2015 Sep 25.

PMID:
26410884
10.

Effect of seafood mediated PCB exposure on desaturase activity and PUFA profile in Faroese septuagenarians.

Tøttenborg SS, Choi AL, Bjerve KS, Weihe P, Grandjean P.

Environ Res. 2015 Jul;140:699-703. doi: 10.1016/j.envres.2015.06.001. Epub 2015 Jun 16.

11.

The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation.

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1246-56. doi: 10.2215/CJN.11931214. Epub 2015 Jun 10.

12.

WT1 and interferon-β-vitamin D association in MS: a longitudinal study.

Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltytė-Benth J, Hovdal H, Myhr KM.

Acta Neurol Scand. 2016 Apr;133(4):309-12. doi: 10.1111/ane.12448. Epub 2015 Jun 2.

PMID:
26037530
13.

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltytė Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T.

J Neuroimmunol. 2015 Mar 15;280:21-8. doi: 10.1016/j.jneuroim.2015.02.001. Epub 2015 Feb 11.

PMID:
25773151
14.

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O.

Mult Scler. 2014 Dec;20(14):1833-40. doi: 10.1177/1352458514533843. Epub 2014 May 19.

PMID:
24842958
15.

Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T.

J Neuroimmunol. 2014 Jun 15;271(1-2):60-5. doi: 10.1016/j.jneuroim.2014.03.014. Epub 2014 Mar 24.

PMID:
24713402
16.

Negative confounding by essential fatty acids in methylmercury neurotoxicity associations.

Choi AL, Mogensen UB, Bjerve KS, Debes F, Weihe P, Grandjean P, Budtz-Jørgensen E.

Neurotoxicol Teratol. 2014 Mar-Apr;42:85-92. doi: 10.1016/j.ntt.2014.02.003. Epub 2014 Feb 20.

17.

Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity.

Holmøy T, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Saltytė Benth J, Torkildsen O, Wergeland S, Myhr KM, Michelsen AE, Aukrust P, Ueland T.

PLoS One. 2013 Sep 19;8(9):e75021. doi: 10.1371/journal.pone.0075021. eCollection 2013.

18.

Visual evoked potentials in children prenatally exposed to methylmercury.

Yorifuji T, Murata K, Bjerve KS, Choi AL, Weihe P, Grandjean P.

Neurotoxicology. 2013 Jul;37:15-8. doi: 10.1016/j.neuro.2013.03.009. Epub 2013 Mar 30.

19.

Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction.

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JŠ, Torkildsen Ø, Wergeland S, Holmøy T.

PLoS One. 2013;8(1):e54417. doi: 10.1371/journal.pone.0054417. Epub 2013 Jan 22.

20.
21.

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Holmøy T.

Mult Scler. 2013 Apr;19(4):451-7. doi: 10.1177/1352458512457843. Epub 2012 Aug 20.

PMID:
22907941
22.
23.

Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients.

Saltytė Benth J, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T.

Neuroepidemiology. 2012;39(2):84-93. doi: 10.1159/000339360. Epub 2012 Jul 17.

24.

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.

Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM.

Neurology. 2012 Jul 17;79(3):267-73. doi: 10.1212/WNL.0b013e31825fdf01. Epub 2012 Jun 13.

PMID:
22700809
25.

ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.

Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Lilleås F, Pedersen T, Bjørnarå B, Dalene F, Kleveland G, Schepel J, Olsen IC, Myhr KM.

Arch Neurol. 2012 Aug;69(8):1044-51. doi: 10.1001/archneurol.2012.283.

PMID:
22507886
26.

[Standardized hemoglobin A1C for diagnostic use?].

Berg JP, Hanssen KF, Bjerve KS, Claudi T, Dahl-Jørgensen K, Rustad P, Sandberg S, Skrivarhaug T.

Tidsskr Nor Laegeforen. 2011 Mar 18;131(6):565-6. doi: 10.4045/tidsskr.10.1160. Norwegian. No abstract available.

27.

Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.

Mostad IL, Bjerve KS, Basu S, Sutton P, Frayn KN, Grill V.

Metabolism. 2009 Dec;58(12):1753-61. doi: 10.1016/j.metabol.2009.06.003. Epub 2009 Aug 27.

PMID:
19716144
28.

Fatty acid desaturase expression in human leucocytes correlates with plasma phospholipid fatty acid status.

Slagsvold JE, Thorstensen K, Kvitland M, Erixon D, Knagenhjelm N, Mack M, Bjerve KS.

Scand J Clin Lab Invest. 2009;69(4):496-504. doi: 10.1080/00365510902759528.

PMID:
19340699
29.

Long-chain n-3 fatty acids and mortality in elderly patients.

Lindberg M, Saltvedt I, Sletvold O, Bjerve KS.

Am J Clin Nutr. 2008 Sep;88(3):722-9.

PMID:
18779289
30.

Regulation of desaturase expression in HL60 cells.

Slagsvold JE, Thorstensen K, Kvitland M, Mack M, Bjerve KS.

Scand J Clin Lab Invest. 2007;67(6):632-42.

PMID:
17852835
31.

Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.

Mostad IL, Bjerve KS, Lydersen S, Grill V.

Eur J Clin Nutr. 2008 Mar;62(3):419-29. Epub 2007 Feb 28.

PMID:
17327864
32.

Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation.

Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V.

Am J Clin Nutr. 2006 Sep;84(3):540-50. Erratum in: Am J Clin Nutr. 2007 Jun;85(6):1668.

PMID:
16960167
34.

Dexamethasone reduces androgen levels in metformin-treated patients with polycystic ovary syndrome.

Vanky E, Kjøtrød SB, Maesel A, Bjerve KS, Carlsen SM.

Fertil Steril. 2004 Feb;81(2):459-62.

PMID:
14967392
35.

Menometrorrhagia in the perimenopause is associated with increased serum estradiol.

Moen MH, Kahn H, Bjerve KS, Halvorsen TB.

Maturitas. 2004 Feb 20;47(2):151-5.

PMID:
14757274
36.

Androgen levels in pregnant women decrease with increasing maternal age.

Carlsen SM, Jacobsen G, Bjerve KS.

Scand J Clin Lab Invest. 2003;63(1):23-6.

PMID:
12729066
37.

Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects.

Qvigstad E, Mostad IL, Bjerve KS, Grill VE.

Am J Physiol Endocrinol Metab. 2003 Jan;284(1):E129-37.

38.

Effects of long-term fasting on insulin responses to fatty acids in man.

Qvigstad E, Bjerve KS, Grill V.

Scand J Clin Lab Invest. 2002;62(4):271-7.

PMID:
12476925
39.

Benefit of population-based screening for phenotypic hemochromatosis in young men.

Asberg A, Tretli S, Hveem K, Bjerve KS.

Scand J Gastroenterol. 2002 Oct;37(10):1212-9.

PMID:
12408528
40.

[Lead poisoning--an overview].

Amundsen T, Naess IA, Hammerstrøm J, Brudevold R, Bjerve KS.

Tidsskr Nor Laegeforen. 2002 Jun 10;122(15):1473-6. Review. Norwegian.

PMID:
12185737
41.

[Lead poisoning--a case report].

Amundsen T, Naess IA, Hammerstrøm J, Brudevold R, Bjerve KS.

Tidsskr Nor Laegeforen. 2002 Jun 10;122(15):1471-2. Norwegian.

42.

Hereditary hemochromatosis: the clinical significance of the S65C mutation.

Asberg A, Thorstensen K, Hveem K, Bjerve KS.

Genet Test. 2002 Spring;6(1):59-62.

PMID:
12180078
43.

Persons with screening-detected haemochromatosis: as healthy as the general population?

Asberg A, Hveem K, Krüger O, Bjerve KS.

Scand J Gastroenterol. 2002 Jun;37(6):719-24.

PMID:
12126253
44.

High headache prevalence among women with hemochromatosis: the Nord-Trøndelag health study.

Hagen K, Stovner LJ, Asberg A, Thorstensen K, Bjerve KS, Hveem K.

Ann Neurol. 2002 Jun;51(6):786-9.

PMID:
12112089
45.

Hereditary haemochromatosis in two cousins with cluster headache.

Stovner LJ, Hagen K, Waage A, Bjerve KS.

Cephalalgia. 2002 May;22(4):317-9.

PMID:
12100096
46.

Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery.

Lindberg M, Hole A, Johnsen H, Asberg A, Rydning A, Myrvold HE, Bjerve KS.

Scand J Clin Lab Invest. 2002;62(3):189-94.

PMID:
12088337
47.

Birthweight in a fishing community: significance of essential fatty acids and marine food contaminants.

Grandjean P, Bjerve KS, Weihe P, Steuerwald U.

Int J Epidemiol. 2001 Dec;30(6):1272-8.

PMID:
11821327
48.

Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons.

Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelønning K, Fjøsne U, Halvorsen TB, Smethurst HB, Sagen E, Bjerve KS.

Scand J Gastroenterol. 2001 Oct;36(10):1108-15.

PMID:
11589387
49.

Detection of an unusual combination of mutations in the HFE gene for hemochromatosis.

Thorstensen K, Asberg A, Kvitland M, Svaasand E, Hveem K, Bjerve KS.

Genet Test. 2000;4(4):371-6.

PMID:
11216661
50.

Detection of alcohol abuse in neurological patients: variables of clinical relevance to the accuracy of the %CDT-TIA and CDTect methods.

Bråthen G, Bjerve KS, Brodtkorb E, Helde G, Bovim G.

Alcohol Clin Exp Res. 2001 Jan;25(1):46-53.

PMID:
11198714

Supplemental Content

Loading ...
Support Center